doi: 10.1038/s41598-021-97967-0 112 AlharbiSH
Extensive analysis of the peptide's stress-protective effects revealed consistent reductions in stress hormone levels and improved stress adaptation across multiple experimental paradigms
These partners are not just leaders in our business but also form a close-knit network of mutual support
Prostate cancer (PCa) is a hormone-dependent cancer for which environmental influences and obesity are established risk factors, with emerging evidence suggesting that obesogens may affect its development and progression
Because semaglutide is not metabolised through the same liver enzyme pathways as cannabinoids, a direct metabolic interaction is unlikely
Key Features Dual-mechanism design: GHRH-receptor agonism (CJC-1295) + GHSR agonism (Ipamorelin) for complementary GH-axis interrogation 99% Purity (HPLC/MS verified): Consistent material for reproducible protocols Protocol-friendly kinetics: Short, high-amplitude GH pulse (Ipamorelin) alongside prolonged GH/IGF-1 support (CJC-1295) in model systems GMP-compliant manufacturing (USA): Batch-to-batch reliability COA included: Full lot documentation Specifications Identity: CJC-1295 /Ipamorelin USA cGMP Produced Form & Sizes: 10 mg vials Appearance: White to off-white lyophilized powder Purity: 99% (HPLC/MS verified) Manufacturing: GMP-compliant facility, USA Storage: 20 C, desiccated
